Colorectal adenoma and carcinoma specific miRNA profiles in biopsy and their expression in plasma specimens

Zsófia Brigitta Nagy, Barnabás Wichmann, Alexandra Kalmár, Orsolya Galamb, Barbara Kinga Barták, Sándor Spisák, Z. Tulassay, B. Molnár

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background: MiRNA expression markers are well characterized in colorectal cancer (CRC), but less is known about miRNA expression profiles in colorectal adenomas. Genome-wide miRNA and mRNA expression analyses were conducted through the colorectal adenoma dysplasia sequence. Furthermore, analysis of the expression levels of miRNAs in matched plasma samples was performed, focusing on biomarker candidates; miRNA and mRNA expression analyses were performed on colorectal biopsies and plasma samples (20 normals; 11 tubular and 9 tubulovillous adenomas; 20 colorectal carcinomas) by miRNA 3.0 and Human Transcriptome Array (Affymetrix) and validated by RT-qPCR. Microarray data were analyzed using Expression Console and mRNA targets were predicted using miRWALK 2.0. Results: Based on microarray analysis, 447 miRNAs were expressed in tissue and 320 in plasma. Twelve were upregulated (miR-31, 8-fold p < 0.001) and 11 were downregulated (miR-10b 3-fold p < 0.001) in neoplastic lesions compared to normal group. Eleven miRNAs showed altered expression between adenoma subtypes (miR-183 2.8-fold change, p < 0.007). Expression level of 24 miRNAs differed between adenoma and CRC groups (including miR-196a, 3.5-fold). Three miRNAs (miR-31, miR-4506, miR-452*) were differentially expressed in adenoma compared to normal both in tissue and plasma samples. miRNA expression data were confirmed by RT-PCR both in plasma and matched tissue samples. Conclusions: MiRNAs showed characteristic expression changes during CRC development in tissue. miRNAs were also presented in plasma and positively correlated with matched tissue expression levels. The identified miRNA expression changes could be verified RT-PCR methods facilitating routine application.

Original languageEnglish
Article number22
JournalClinical Epigenetics
Volume9
Issue number1
DOIs
Publication statusPublished - Feb 14 2017

Fingerprint

MicroRNAs
Adenoma
Colorectal Neoplasms
Biopsy
Messenger RNA
Polymerase Chain Reaction
Microarray Analysis
Transcriptome
Down-Regulation
Biomarkers
Genome

Keywords

  • Colorectal adenoma
  • Colorectal cancer
  • Microarray
  • microRNA
  • miRNA profiling
  • Real-time PCR

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Developmental Biology
  • Genetics(clinical)

Cite this

Colorectal adenoma and carcinoma specific miRNA profiles in biopsy and their expression in plasma specimens. / Nagy, Zsófia Brigitta; Wichmann, Barnabás; Kalmár, Alexandra; Galamb, Orsolya; Barták, Barbara Kinga; Spisák, Sándor; Tulassay, Z.; Molnár, B.

In: Clinical Epigenetics, Vol. 9, No. 1, 22, 14.02.2017.

Research output: Contribution to journalArticle

Nagy, Zsófia Brigitta ; Wichmann, Barnabás ; Kalmár, Alexandra ; Galamb, Orsolya ; Barták, Barbara Kinga ; Spisák, Sándor ; Tulassay, Z. ; Molnár, B. / Colorectal adenoma and carcinoma specific miRNA profiles in biopsy and their expression in plasma specimens. In: Clinical Epigenetics. 2017 ; Vol. 9, No. 1.
@article{a133e7461d574dcbbe98062fab9e81d9,
title = "Colorectal adenoma and carcinoma specific miRNA profiles in biopsy and their expression in plasma specimens",
abstract = "Background: MiRNA expression markers are well characterized in colorectal cancer (CRC), but less is known about miRNA expression profiles in colorectal adenomas. Genome-wide miRNA and mRNA expression analyses were conducted through the colorectal adenoma dysplasia sequence. Furthermore, analysis of the expression levels of miRNAs in matched plasma samples was performed, focusing on biomarker candidates; miRNA and mRNA expression analyses were performed on colorectal biopsies and plasma samples (20 normals; 11 tubular and 9 tubulovillous adenomas; 20 colorectal carcinomas) by miRNA 3.0 and Human Transcriptome Array (Affymetrix) and validated by RT-qPCR. Microarray data were analyzed using Expression Console and mRNA targets were predicted using miRWALK 2.0. Results: Based on microarray analysis, 447 miRNAs were expressed in tissue and 320 in plasma. Twelve were upregulated (miR-31, 8-fold p < 0.001) and 11 were downregulated (miR-10b 3-fold p < 0.001) in neoplastic lesions compared to normal group. Eleven miRNAs showed altered expression between adenoma subtypes (miR-183 2.8-fold change, p < 0.007). Expression level of 24 miRNAs differed between adenoma and CRC groups (including miR-196a, 3.5-fold). Three miRNAs (miR-31, miR-4506, miR-452*) were differentially expressed in adenoma compared to normal both in tissue and plasma samples. miRNA expression data were confirmed by RT-PCR both in plasma and matched tissue samples. Conclusions: MiRNAs showed characteristic expression changes during CRC development in tissue. miRNAs were also presented in plasma and positively correlated with matched tissue expression levels. The identified miRNA expression changes could be verified RT-PCR methods facilitating routine application.",
keywords = "Colorectal adenoma, Colorectal cancer, Microarray, microRNA, miRNA profiling, Real-time PCR",
author = "Nagy, {Zs{\'o}fia Brigitta} and Barnab{\'a}s Wichmann and Alexandra Kalm{\'a}r and Orsolya Galamb and Bart{\'a}k, {Barbara Kinga} and S{\'a}ndor Spis{\'a}k and Z. Tulassay and B. Moln{\'a}r",
year = "2017",
month = "2",
day = "14",
doi = "10.1186/s13148-016-0305-3",
language = "English",
volume = "9",
journal = "Clinical Epigenetics",
issn = "1868-7075",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Colorectal adenoma and carcinoma specific miRNA profiles in biopsy and their expression in plasma specimens

AU - Nagy, Zsófia Brigitta

AU - Wichmann, Barnabás

AU - Kalmár, Alexandra

AU - Galamb, Orsolya

AU - Barták, Barbara Kinga

AU - Spisák, Sándor

AU - Tulassay, Z.

AU - Molnár, B.

PY - 2017/2/14

Y1 - 2017/2/14

N2 - Background: MiRNA expression markers are well characterized in colorectal cancer (CRC), but less is known about miRNA expression profiles in colorectal adenomas. Genome-wide miRNA and mRNA expression analyses were conducted through the colorectal adenoma dysplasia sequence. Furthermore, analysis of the expression levels of miRNAs in matched plasma samples was performed, focusing on biomarker candidates; miRNA and mRNA expression analyses were performed on colorectal biopsies and plasma samples (20 normals; 11 tubular and 9 tubulovillous adenomas; 20 colorectal carcinomas) by miRNA 3.0 and Human Transcriptome Array (Affymetrix) and validated by RT-qPCR. Microarray data were analyzed using Expression Console and mRNA targets were predicted using miRWALK 2.0. Results: Based on microarray analysis, 447 miRNAs were expressed in tissue and 320 in plasma. Twelve were upregulated (miR-31, 8-fold p < 0.001) and 11 were downregulated (miR-10b 3-fold p < 0.001) in neoplastic lesions compared to normal group. Eleven miRNAs showed altered expression between adenoma subtypes (miR-183 2.8-fold change, p < 0.007). Expression level of 24 miRNAs differed between adenoma and CRC groups (including miR-196a, 3.5-fold). Three miRNAs (miR-31, miR-4506, miR-452*) were differentially expressed in adenoma compared to normal both in tissue and plasma samples. miRNA expression data were confirmed by RT-PCR both in plasma and matched tissue samples. Conclusions: MiRNAs showed characteristic expression changes during CRC development in tissue. miRNAs were also presented in plasma and positively correlated with matched tissue expression levels. The identified miRNA expression changes could be verified RT-PCR methods facilitating routine application.

AB - Background: MiRNA expression markers are well characterized in colorectal cancer (CRC), but less is known about miRNA expression profiles in colorectal adenomas. Genome-wide miRNA and mRNA expression analyses were conducted through the colorectal adenoma dysplasia sequence. Furthermore, analysis of the expression levels of miRNAs in matched plasma samples was performed, focusing on biomarker candidates; miRNA and mRNA expression analyses were performed on colorectal biopsies and plasma samples (20 normals; 11 tubular and 9 tubulovillous adenomas; 20 colorectal carcinomas) by miRNA 3.0 and Human Transcriptome Array (Affymetrix) and validated by RT-qPCR. Microarray data were analyzed using Expression Console and mRNA targets were predicted using miRWALK 2.0. Results: Based on microarray analysis, 447 miRNAs were expressed in tissue and 320 in plasma. Twelve were upregulated (miR-31, 8-fold p < 0.001) and 11 were downregulated (miR-10b 3-fold p < 0.001) in neoplastic lesions compared to normal group. Eleven miRNAs showed altered expression between adenoma subtypes (miR-183 2.8-fold change, p < 0.007). Expression level of 24 miRNAs differed between adenoma and CRC groups (including miR-196a, 3.5-fold). Three miRNAs (miR-31, miR-4506, miR-452*) were differentially expressed in adenoma compared to normal both in tissue and plasma samples. miRNA expression data were confirmed by RT-PCR both in plasma and matched tissue samples. Conclusions: MiRNAs showed characteristic expression changes during CRC development in tissue. miRNAs were also presented in plasma and positively correlated with matched tissue expression levels. The identified miRNA expression changes could be verified RT-PCR methods facilitating routine application.

KW - Colorectal adenoma

KW - Colorectal cancer

KW - Microarray

KW - microRNA

KW - miRNA profiling

KW - Real-time PCR

UR - http://www.scopus.com/inward/record.url?scp=85012214835&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85012214835&partnerID=8YFLogxK

U2 - 10.1186/s13148-016-0305-3

DO - 10.1186/s13148-016-0305-3

M3 - Article

C2 - 28289479

AN - SCOPUS:85012214835

VL - 9

JO - Clinical Epigenetics

JF - Clinical Epigenetics

SN - 1868-7075

IS - 1

M1 - 22

ER -